New insight into unexpected bone formation by denosumab
Lipeng Wang1, Biaotong Huang2, Xiao Chen3
1Graduate Management Unit, Shanghai Changhai Hospital, Naval Medical University, 168 Changhai Road, Shanghai 200433, China.
Drug Discovery Today
|September 11, 2020
Summary
Denosumab, a monoclonal antibody for osteoporosis, increases bone mass by blocking RANKL. This study explores RANKL and reverse signaling in Dmab's bone-forming effects, clarifying its controversial mechanisms.
Area of Science:
- Endocrinology
- Bone Biology
- Pharmacology
Background:
- Denosumab (Dmab) is the first monoclonal antibody (mAb) approved for osteoporosis treatment.
- Dmab inhibits receptor activator for nuclear factor κB ligand (RANKL), acting as an antiresorptive agent.
- Dmab treatment paradoxically increases bone mass, with mechanisms under investigation.
Purpose of the Study:
- To discuss the roles of RANKL signaling in Dmab's bone-forming effects.
- To investigate the contribution of RANKL reverse signaling to Dmab's anabolic actions.
Main Methods:
- Review of recent findings on RANKL signaling pathways.
- Analysis of RANKL reverse signaling in bone remodeling.
- Discussion of Dmab's impact on osteoblastogenesis and bone formation.
Main Results:
- RANKL signaling influences osteoblastogenesis and bone formation.
- RANKL reverse signaling plays a role in coupling bone resorption and formation.
- These signaling pathways contribute to Dmab's observed increase in bone mass.
Conclusions:
- RANKL and reverse RANKL signaling are key to understanding Denosumab's bone-forming effects.
- Further research into these pathways may reveal new therapeutic targets for osteoporosis.
Related Concept Videos
01:40Bone Remodeling
39.9K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.9K
01:31Osteoclasts in Bone Remodeling
3.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.6K
01:24Bone Formation by Endochondral Ossification
7.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.6K
01:29Bone Formation by Intramembranous Ossification
9.5K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.5K
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:55Bone Structure
51.0K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
51.0K